BD Synapsys™ – Insufficient Session Expiration
13Vexday Risk Score
No sign of exploitation. No public exploitation artifact known so far.
ssvc Trackcvss 5.7epss 0.2%
exploitation probability
0.2%top 87% of all CVEs
observed exploitation
nono source reports it
BD Synapsys™, versions 4.20, 4.20 SR1, and 4.30, contain an insufficient session expiration vulnerability. If exploited, threat actors may be able to access, modify or delete sensitive information, including electronic protected health information (ePHI), protected health information (PHI) and personally identifiable information (PII).
CVSS:3.1/AV:P/AC:L/PR:L/UI:R/S:U/C:H/I:H/A:N
Affected products
Becton Dickinson (BD) · BD Synapsys™